Vesicular Antibodies A Bioactive Multifunctional Combination Platform for Targeted Therapeutic Delivery and Cancer Immunotherapy

Vesicular Antibodies : A Bioactive Multifunctional Combination Platform for Targeted Therapeutic Delivery and Cancer Immunotherapy

© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Détails bibliographiques
Publié dans:Advanced materials (Deerfield Beach, Fla.). - 1998. - 31(2019), 17 vom: 06. Apr., Seite e1808294
Auteur principal: Liu, Xue (Auteur)
Autres auteurs: Liu, Chao, Zheng, Zizheng, Chen, Siyuan, Pang, Xin, Xiang, Xinchu, Tang, Jixian, Ren, En, Chen, Yuanzhi, You, Min, Wang, Xiaoyong, Chen, Xiaoyuan, Luo, Wenxin, Liu, Gang, Xia, Ningshao
Format: Article en ligne
Langue:English
Publié: 2019
Accès à la collection:Advanced materials (Deerfield Beach, Fla.)
Sujets:Journal Article chemotherapy full-length antibodies immunotherapy membrane nanovesicles theranostics Antibodies, Monoclonal Antigens, Neoplasm Antineoplastic Agents Drug Carriers plus... Photosensitizing Agents Doxorubicin 80168379AG Indocyanine Green IX6J1063HV
LEADER 01000caa a22002652 4500
001 NLM294718141
003 DE-627
005 20250225001022.0
007 cr uuu---uuuuu
008 231225s2019 xx |||||o 00| ||eng c
024 7 |a 10.1002/adma.201808294  |2 doi 
028 5 2 |a pubmed25n0982.xml 
035 |a (DE-627)NLM294718141 
035 |a (NLM)30848011 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Liu, Xue  |e verfasserin  |4 aut 
245 1 0 |a Vesicular Antibodies  |b A Bioactive Multifunctional Combination Platform for Targeted Therapeutic Delivery and Cancer Immunotherapy 
264 1 |c 2019 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 27.11.2019 
500 |a Date Revised 30.09.2020 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a © 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. 
520 |a The ability to selectively kill cancerous cell populations while leaving healthy cells unaffected is a key goal in oncology. The use of nanovesicles (NVs) as chemotherapeutic delivery vehicles has been recently proven successful, yet monotherapy with monomodalities remains a significant limitation for solid tumor treatment. Here, as a proof of principle, a novel cell-membrane-derived NVs that can display full-length monoclonal antibodies (mAbs) is engineered. The high affinity and specificity of mAb for tumor-specific antigens allow these vesicular antibodies (VAs) to selectively deliver a cytotoxic agent to tumor cells and exert potent inhibition effects. These VAs can also regulate the tumor immune microenvironment. They can mediate antibody-dependent cellular cytotoxicity to eradicate tumor cells via recruitment and activation of natural killer cells in the tumor. Upon further encapsulation with chemotherapeutic agents, the VAs show unequaled cooperative effects in chemotherapy and immunotherapy in tumor-bearing mice. As far as it is known, this is the first report of a VA-based multifunctional combination therapy platform. This might lead to additional applications of vesicular antibodies in cancer theranostics 
650 4 |a Journal Article 
650 4 |a chemotherapy 
650 4 |a full-length antibodies 
650 4 |a immunotherapy 
650 4 |a membrane nanovesicles 
650 4 |a theranostics 
650 7 |a Antibodies, Monoclonal  |2 NLM 
650 7 |a Antigens, Neoplasm  |2 NLM 
650 7 |a Antineoplastic Agents  |2 NLM 
650 7 |a Drug Carriers  |2 NLM 
650 7 |a Photosensitizing Agents  |2 NLM 
650 7 |a Doxorubicin  |2 NLM 
650 7 |a 80168379AG  |2 NLM 
650 7 |a Indocyanine Green  |2 NLM 
650 7 |a IX6J1063HV  |2 NLM 
700 1 |a Liu, Chao  |e verfasserin  |4 aut 
700 1 |a Zheng, Zizheng  |e verfasserin  |4 aut 
700 1 |a Chen, Siyuan  |e verfasserin  |4 aut 
700 1 |a Pang, Xin  |e verfasserin  |4 aut 
700 1 |a Xiang, Xinchu  |e verfasserin  |4 aut 
700 1 |a Tang, Jixian  |e verfasserin  |4 aut 
700 1 |a Ren, En  |e verfasserin  |4 aut 
700 1 |a Chen, Yuanzhi  |e verfasserin  |4 aut 
700 1 |a You, Min  |e verfasserin  |4 aut 
700 1 |a Wang, Xiaoyong  |e verfasserin  |4 aut 
700 1 |a Chen, Xiaoyuan  |e verfasserin  |4 aut 
700 1 |a Luo, Wenxin  |e verfasserin  |4 aut 
700 1 |a Liu, Gang  |e verfasserin  |4 aut 
700 1 |a Xia, Ningshao  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Advanced materials (Deerfield Beach, Fla.)  |d 1998  |g 31(2019), 17 vom: 06. Apr., Seite e1808294  |w (DE-627)NLM098206397  |x 1521-4095  |7 nnns 
773 1 8 |g volume:31  |g year:2019  |g number:17  |g day:06  |g month:04  |g pages:e1808294 
856 4 0 |u http://dx.doi.org/10.1002/adma.201808294  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 31  |j 2019  |e 17  |b 06  |c 04  |h e1808294